AI Article Synopsis

  • A novel tDCS device was developed that minimizes electrical artifacts, enabling simultaneous EEG measurements during stimulation.
  • The study involved 10 participants, measuring EEG data in various states (EO and EC) across five conditions (baseline, sham, post-sham, tDCS, post-tDCS).
  • Findings showed significant increases in alpha frequency power and brain network indices during and after tDCS application, highlighting the device's effectiveness in neuromodulation without interference from artifacts.

Article Abstract

Recently, we introduced a current limiter-based novel transcranial direct-current stimulation (tDCS) device that does not generate significant tDCS-induced electrical artifacts, thereby facilitating simultaneous electroencephalography (EEG) measurement during tDCS application. In this study, we investigated the neuromodulatory effect of the tDCS device using resting-state EEG data measured during tDCS application in terms of EEG power spectral densities (PSD) and brain network indices (clustering coefficient and path length). Resting-state EEG data were recorded from 10 healthy subjects during both eyes-open (EO) and eyes-closed (EC) states for each of five different conditions (baseline, sham, post-sham, tDCS, and post-tDCS). In the tDCS condition, tDCS was applied for 12 min with a current intensity of 1.5 mA, whereas tDCS was applied only for the first 30 s in the sham condition. EEG PSD and brain network indices were computed for the alpha frequency band most closely associated with resting-state EEG. Both alpha PSD and network indices were found to significantly increase during and after tDCS application compared to those of the baseline condition in the EO state, but not in the EC state owing to the ceiling effect. Our results demonstrate the neuromodulatory effect of the tDCS device that does not generate significant tDCS-induced electrical artifacts, thereby allowing simultaneous measurement of electrical brain activity. We expect our novel tDCS device to be practically useful in exploring the impact of tDCS on neuromodulation more precisely using ongoing EEG data simultaneously measured during tDCS application.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382376PMC
http://dx.doi.org/10.1007/s13534-023-00269-9DOI Listing

Publication Analysis

Top Keywords

tdcs device
20
tdcs application
16
tdcs
14
resting-state eeg
12
eeg data
12
network indices
12
current limiter-based
8
device resting-state
8
device generate
8
generate tdcs-induced
8

Similar Publications

Spectrum sensing is a key technology and prerequisite for Transform Domain Communication Systems (TDCS). The traditional approach typically involves selecting a working sub-band and maintaining it without further changes, with spectrum sensing being conducted periodically. However, this approach presents two main issues: on the one hand, if the selected working band has few idle channels, TDCS devices are unable to flexibly switch sub-bands, leading to reduced performance; on the other hand, periodic sensing consumes time and energy, limiting TDCS's transmission efficiency.

View Article and Find Full Text PDF

Objective: Non-invasive neuromodulation techniques, particularly transcranial direct current stimulation (tDCS), are promising for drug-resistant epilepsy (DRE), though the mechanisms of their efficacy remain unclear. This study aims to (i) investigate tDCS neurophysiological mechanisms using a personalized multichannel protocol with magnetoencephalography (MEG) and (ii) assess post-tDCS changes in brain connectivity, correlating them with clinical outcomes.

Methods: Seventeen patients with focal DRE underwent three cycles of tDCS over five days, each consisting of 40-minute stimulations targeting the epileptogenic zone (EZ) identified via stereo-EEG.

View Article and Find Full Text PDF

Bipolar depression is commonly accompanied by cognitive impairments. Transcranial direct current stimulation (tDCS) is emerging as a novel non-invasive treatment for bipolar depression. Given the portability and safety of tDCS, we developed a home-based protocol with real-time supervision.

View Article and Find Full Text PDF

Introduction: The seizures in Lennox-Gastaut syndrome are typically resistant to treatment. Seven antiseizure medications (ASMs) in the US (six in the UK/EU) are licensed for the treatment of seizures in LGS: lamotrigine, topiramate, rufinamide, clobazam, felbamate (not licensed in the UK/EU), cannabidiol and fenfluramine. Other options include neurostimulation, corpus callosotomy and dietary therapies, principally the ketogenic diet and its variants.

View Article and Find Full Text PDF

Objectives: Following anterior cruciate ligament reconstruction (ACLR), maladaptive changes occur in the motor cortex representation of the quadriceps, evidenced by increases in intracortical inhibition and facilitation. The primary objective of this proof-of-concept study was to determine if anodal transcranial direct current stimulation (tDCS) can alter quadriceps intracortical inhibition and facilitation in an early-ACLR population after 6 weeks of application during exercise.

Methods: We performed a randomised, triple-blind controlled trial for proof of concept comparing anodal-tDCS to sham-tDCS following ACLR.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!